Kim Arvid Nielsen
Plus aucun poste en cours
Profil
Kim Arvid Nielsen is the founder of Scandion Oncology A, which was founded in 2017.
He served as the Chief Executive Officer at Serendex Pharmaceuticals A from 2013 to 2016.
He was also the Chief Executive Officer at Pharmaorigin A.
He served as the Chief Executive Officer at CytoVac AS from 2017 to 2020 and at Hervolution ApS in 2020.
He is currently an Independent Director at Brain+ A since 2019.
He served as the Global Vice President-Strategic Operations at Ferrosan ApS from 1998 to 2002 and as the General Manager at Basilea Pharmaceuticals A from 2007 to 2012.
Dr. Nielsen holds a doctorate from the University of Copenhagen and an MBA from the Scandinavian International Management Institute.
Anciens postes connus de Kim Arvid Nielsen
| Sociétés | Poste | Fin |
|---|---|---|
| BRAIN+ A/S | Directeur/Membre du Conseil | 02/09/2022 |
| FOLLICUM AB (PUBL) | Directeur Général | 29/07/2021 |
Inprother ApS
 Inprother ApS BiotechnologyHealth Technology Inprother ApS is a biotechnology company based in Copenhagen, Denmark. The Danish company aims to develop novel immunotherapies that target the human endogenous retroviruses (HERVs) as tumor-specific antigens. The company is funded by the Novo Nordisk Bioinnovation Institute and by grants from the Danish Innovation Fund and Eurostars. Inprother has put in place a world-class scientific team and created an emerging product development pipeline, including a leading program targeted to enter clinics in 2024. Inprother's approach is based on the research of founder and CTO, Dr. Peter Holst, and CTO, Dr. Anne-Marie Andersson. The company was founded in 2011 by Peter Johannes Holst. Jordi Naval has been the CEO of the company since 2021. | Directeur Général | 01/11/2020 |
CytoVac AS
 CytoVac AS BiotechnologyHealth Technology CytoVac AS manufactures pharmaceuticals. The private company is based in Hørsholm, Denmark. The Danish company was founded in 2008. The CEO is Lone Dahl Andersen. | Directeur Général | 01/01/2020 |
| SCANDION ONCOLOGY A/S | Fondateur | 01/05/2018 |
Formation de Kim Arvid Nielsen
| University of Copenhagen | Doctorate Degree |
| Scandinavian International Management Institute | Masters Business Admin |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Sociétés cotées | 2 |
|---|---|
| SCANDION ONCOLOGY A/S | Health Technology |
| BRAIN+ A/S | Technology Services |
| Entreprise privées | 7 |
|---|---|
Pharmaorigin A/S
 Pharmaorigin A/S Pharmaceuticals: MajorHealth Technology Pharmaorigin ApS is a holding company that provides medical treatment. It offers medication for prevention of bleeding in surgical interventions or invasive procedures in patients with acquired hemophilia. The company was founded by Lars Heslet on November 14, 2005 and is headquartered in H?rsholm, Denmark. | Health Technology |
Serendex Pharmaceuticals A/S
 Serendex Pharmaceuticals A/S Pharmaceuticals: MajorHealth Technology Serendex Pharmaceuticals A/S engages in the research and development of pharmaceuticals for respiratory conditions. It develops drugs to treat respiratory conditions such as Pulmonary Alveolar Proteinosis, Bronchiectasis, Cystic Fibrosis related lung infections and Diffuse Alveolar Hemorrhage. The company was founded by Lars Heslet on October 31, 2008 and is headquartered in Horsholm, Denmark. | Health Technology |
Ferrosan ApS
 Ferrosan ApS Pharmaceuticals: OtherHealth Technology Ferrosan ApS manufactures and sells pharmaceutical products. Its products include herbal medicine, natural remedies, food supplements, and medical devices. The company was founded by Niels Jacob Herman Weitzmann in 1920 and is headquartered in Ballerup, Denmark. | Health Technology |
| Basilea Pharmaceuticals A/S | |
Follicum AB
 Follicum AB Pharmaceuticals: MajorHealth Technology Follicum AB is a biotech company, which engages in discovery and development of peptide-based drugs. Its product pipeline include FOL-005, FOL-00X, FOL-014, and FOL-00Y which is made for stimulation of hair growth and treatment of diabetes. The company was founded by Anna Kerstin Emy Hultgårdh Nilsson and Claes Pontus Dunér on May 3, 2011 and is headquartered in Lund, Sweden. | Health Technology |
Inprother ApS
Inprother ApS BiotechnologyHealth Technology Inprother ApS is a biotechnology company based in Copenhagen, Denmark. The Danish company aims to develop novel immunotherapies that target the human endogenous retroviruses (HERVs) as tumor-specific antigens. The company is funded by the Novo Nordisk Bioinnovation Institute and by grants from the Danish Innovation Fund and Eurostars. Inprother has put in place a world-class scientific team and created an emerging product development pipeline, including a leading program targeted to enter clinics in 2024. Inprother's approach is based on the research of founder and CTO, Dr. Peter Holst, and CTO, Dr. Anne-Marie Andersson. The company was founded in 2011 by Peter Johannes Holst. Jordi Naval has been the CEO of the company since 2021. | Health Technology |
CytoVac AS
CytoVac AS BiotechnologyHealth Technology CytoVac AS manufactures pharmaceuticals. The private company is based in Hørsholm, Denmark. The Danish company was founded in 2008. The CEO is Lone Dahl Andersen. | Health Technology |
